LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
191,700
+4,400 (2.35%)
Feb 27, 2026, 3:30 PM KST
68.60%
Market Cap 6.98T
Revenue (ttm) 159.27B
Net Income (ttm) -25.13B
Shares Out 36.41M
EPS (ttm) -690.95
PE Ratio n/a
Forward PE 174.40
Dividend n/a
Ex-Dividend Date n/a
Volume 368,522
Average Volume 436,484
Open 187,300
Previous Close 187,300
Day's Range 186,000 - 194,200
52-Week Range 89,500 - 221,500
Beta 0.73
RSI 58.76
Earnings Date Mar 20, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.